Global /Ireland /Healthcare /Drug Manufacturers - Specialty & Generic /PRGO
chevron_leftBack

Perrigo Company plc

PRGO
NYSE: PRGO Delayed
24.74USD -0.3%
As of 24 April 2025, Perrigo Company plc has a market cap of $3.38B USD, ranking #3787 globally and #24 in Ireland. It ranks #320 in the Healthcare sector, and #55 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
3787
Country Rank
24
Sector Rank
320
Industry Rank
55
Key Stats
Market Cap
$3.38BUSD
Enterprise Value
$6.64BUSD
Revenue (TTM)
$4.37BUSD
EBITDA (TTM)
$743.2MUSD
Net Income (TTM)
-$171.8MUSD
EBITDA Margin
17%
Profit Margin
-3.9%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Patrick Lockwood-Taylor open_in_new
Employees
8,379
Founded
1887
IPO
16 Dec 1991
Website
perrigo.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.3% -1.6% -11% 2.9% -4.2% -18%
Upcoming Earnings
Earnings Date
Tue, May 6
Earnings Time
sunny Before Open
EPS Estimate
$0.5400 86% yoy
Revenue Estimate
$1.09B 0.7% yoy

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
PRGO
Perrigo Co PLC
ISIN: IE00BGH1M568
Shares Out.:
136.459M1 Shares Float: 135.842M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
24.74 USD
London Stock Exchange
MIC: XLON
0Y5E
Perrigo Co PLC
ISIN: IE00BGH1M568
TV:
SA:
YF:
GF:
BA:
MS:
25.38 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Ireland)
Name
Market Cap diff.
Alkermes plc
ALKS
$4.48B
33%
A
Avadel Pharmaceuticals plc
AVDL
$802.99M
-76%
Malin Corporation plc
MLC
$44.83M
39.4M EUR
-99%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
2K%
Merck KGaA
MRK
$59.67B
52.43B EUR
2K%
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
1K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
1K%
Haleon plc
HLN
$45.68B
34.34B GBP
1K%